β-hydroxy-β-methylbutyrate (HMB)

DIETARY_SUPPLEMENT3 trials

Sponsors

University of Erlangen-Nürnberg Medical School, Universidad de Burgos, Duke University

Conditions

AgingAmyotrophic Lateral Sclerosis ALSCancerCancer CachexiaFrailtyMalnutrition ElderlyMuscle LossMuscle Weakness

Phase 1

A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

Not yet recruitingNCT07589764

Duke UniversityAmyotrophic Lateral Sclerosis ALS

Start: 2026-07-01End: 2026-08-01Target: 100Updated: 2026-05-15

Unknown Phase

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical SchoolCancer, Cancer Cachexia, Muscle Loss +2

Start: 2016-12-31End: 2019-04-30Target: 200Updated: 2018-10-16

Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Function in Sarcopenic Frailty

Active, not recruitingNCT07275996

Universidad de BurgosAging, Frailty, Malnutrition Elderly +1

Start: 2026-03-10End: 2027-05-30Updated: 2026-05-04